98996-94-2Relevant academic research and scientific papers
QUINOXALINE COMPOUNDS AND USE THEREOF
-
Page/Page column 91-92, (2008/12/08)
The present invention is related to quinoxaline compounds of Formula (I) in particular for the treatment of autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, bacterial or viral infections, kidney diseases, platelet aggregation, cancer, transplantation, graft rejection or lung injuries.
Process for preparing isomerically pure prodrugs of proton pump inhibitors
-
Page/Page column 21, (2010/02/10)
Synthetic methods for preparing isomerically pure N-arylsulfonyl derivatives of proton pump inhibitors which include a substituted benzimidazole nucleus are shown by the synthetic schemes and experimental description.
PRODRUGS OF PROTON PUMP INHIBITORS
-
Page 190, (2010/02/06)
Prodrugs of proton pump inhibitors of Formulas 1 through 4, (I-IV), where the symbols are as defined in the specification, and the R group includes at least one acidic group or its pharmaceutically acceptable salt, have improved aqueous solubility and bioavailability.
